Trial Profile
Effect of gastric acid suppression by use of vonoplazan
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Jan 2017
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary)
- Indications Duodenal ulcer; Erosive oesophagitis; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer; Reflux oesophagitis
- Focus Therapeutic Use
- 03 Jan 2017 New trial record